The aim of this study was to assess the clinical applicability of three highly sensitive and specific polymerase chain reaction (PCR) techniques, and to perform robust molecular analysis of EGFR activating mutations in scant samples of central nervous system (CNS) metastases from Caucasian patients with advanced NSCLC. Here, EGFR is linked to non-small cell lung carcinoma.